6-MAPDB

6-MAPDB
Clinical data
Other names	6-(2-(Methylamino)propyl)-2,3-dihydrobenzofuran; 1-(2,3-Dihydrobenzofuran-6-yl)-N-methylpropan-2-amine
Legal status
Legal status	CA: Schedule I; DE: NpSG (Industrial and scientific use only); UK: Class B;
Identifiers
	IUPAC name 1-(2,3-dihydro-1-benzofuran-6-yl)-N-methylpropan-2-amine;
CAS Number	1354631-81-4;
PubChem CID	112500534;
ChemSpider	32078889;
UNII	1C25E596YG;
CompTox Dashboard (EPA)	DTXSID301045393 ;
Chemical and physical data
Formula	C12H17NO
Molar mass	191.274 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(CC1=CC2=C(CCO2)C=C1)NC;
	InChI InChI=1S/C12H17NO/c1-9(13-2)7-10-3-4-11-5-6-14-12(11)8-10/h3-4,8-9,13H,5-7H2,1-2H3; Key:ZKMVEORLSJXOBD-UHFFFAOYSA-N;

6-MAPDB, also known as 6-(2-(methylamino)propyl)-2,3-dihydrobenzofuran, is a chemical compound which may be an entactogen of the dihydrobenzofuran family. It is structurally related to drugs like 6-APDB and 6-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 6-MAPDB has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser.